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ABSTRACT 
Epidemiological data demonstrate that regular dietary intake of plant-derived foods and 
beverages reduce the risk of coronary heart disease and stroke. Among many 
ingredients cocoa might be an important mediator. Recent research indeed 
demonstrates beneficial effect of cocoa on blood pressure, insulin resistance, vascular- 
and platelet function.  
Although still debated, a range of potential mechanisms through which cocoa might 
exert its benefits on cardiovascular health have been proposed, among them activation 
of nitric oxide, antioxidant and anti-inflammatory effects. 
This review summarizes the available data about cardiovascular effects of cocoa and 
outlines potential mechanisms involved in the response to cocoa and highlights the 
potential clinical implications associated with its consumption.  
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INTRODUCTION 
 For centuries, cocoa-rich chocolate has not only been known for its good taste, but 
also for its proposed health effects. Indeed, the Inkas considered it the drink of gods; an 
association giving rise to the scientific name of the cocoa tree theobroma cacao, from 
the Greek words "theo" (god) and "broma" (drink). The first hints of cocoa consumption 
date back to 1600 BC. In Honduras, archeologists uncovered elaborately designed 
bowls of this period that are believed to have served the Aztecs to drink liquid cocoa 
thousands of years ago.1 In the 16th century, Aztec Emperor Montezuma was a keen 
admirer of cocoa, calling it a "divine drink, which builds up resistance and fights fatigue. 
A cup of this precious drink permits a man to walk for a whole day without food. “ In the 
language of the Aztecs this drink was called “chocolatl”. With the discovery of the New 
World cocoa came to Europe in the 16th century.2 Since then modern chocolate industry 
has risen and cocoa seeds are now processed in different ways.  
 Several supposed health effects of cocoa have been considered, including 
improved heart function and relief of angina pectoris, stimulation of the nervous system, 
facilitated digestion, and improved kidney and bowel function. In addition, cocoa has 
been used for the treatment of anemia, mental fatigue, tuberculosis, fever, gout, kidney 
stones and even poor sexual appetite.2 In the 19th century, chocolate has become a 
luxury item and hence its consumption a sin rather than a remedy. Indeed, nowadays 
chocolate is associated with carries, obesity, high blood pressure and diabetes. 
Therefore many physicians currently tend to warn patients about the potential health 
hazards of consuming large amount of chocolate-based nutrients.  However, the more 
recent discovery of biologically active phenolic compounds in cocoa has changed this 
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perception3 and stimulated research on its effects in ageing, blood pressure regulation 
and atherosclerosis.  
In this manuscript, we review the clinical relevant cardiovascular effects of cocoa, focus 
on potential mechanisms involved in the response to cocoa and the potential clinical 
implications associated with its consumption. It is important to strictly differentiate 
between the natural product “cacao” and the processed product “chocolate”, which 
refers to the combination of cocoa, sugar, eventually milk and other ingredients in a solid 
food product. Hence, many of the discussed health effects of cocoa and its contents 
may not be applicable for chocolate.  
 
EPIDEMIOLOGICAL EVIDENCE  
Epidemiological data demonstrate that regular dietary intake of plant-derived 
foods and beverages reduces the risk of coronary heart disease4-7 and stroke8 and is 
inversely associated with the risk of cardiovascular disease.5, 7 
First evidence of a similar effect of cocoa was obtained in Kuna Indians, a native 
population living on islands off the coast of Panama. The Kuna belong to one of the few 
cultures, which are protected against the age-dependent increase in blood pressure and 
the development of arterial hypertension. Interestingly, the Kunas consume enormous 
amounts of cocoa daily, sometimes even enriched with salt.9 Clinical studies revealed, 
that the Kuna indeed have lower blood pressure values9 and no age-dependent decline 
in kidney function.10 Moreover, in this native population mortality due to cardiovascular 
events is markedly lower, compared to other panamerican citizens (from 83.4±0.7 age 
adjusted death/100’000 to 9.2±3.1/100’000).11 The factors involved are clearly 
environmental, rather than genetic, as this protection is lost upon migration to urban 
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Panama City, where the home-prepared cocoa is replaced by other food with a lower 
flavanol content.9 
A prospective study in 34 489 postmenopausal women with a 16 years follow-up 
in the Iowa Women's Health Study who were free of cardiovascular disease found that 
food rich in flavonoids were associated with a decreased risk of death due to coronary 
heart disease. Furthermore a borderline significant inverse association between 
chocolate intake and cardiovascular mortality after multivariate adjustment was 
observed.12 Furthermore, the Dutch Zutphen Study provided important further data:  In a 
cross-sectional analysis cocoa intake was inversely related to blood pressure and in a 
prospective analysis intake was associated with a reduction of cardiovascular and all-
cause mortality.13 Indeed, the Zutphen Elderly Study involving 470 elderly men free of 
chronic disease highlighted the protective effects of coca intake. After adjustment for 
age, body mass index, lifestyle factors, drug use, food and caloric intake, the risk of 
cardiovascular mortality for men in the highest tertile of cocoa intake was reduced by 
50%, compared to the lowest tertile (p=0.004). The adjusted relative risk for all-cause 
mortality was 0.53 (95% CI, 0.39-0.72, p=<0.001). 
  
COCOA POLYPHENOLS 
These epidemiological observations led to the hypothesis that such health 
benefits might be linked, at least in part, to plant-derived flavonoids, a large subgroup of 
the heterogeneous group of polyphenols. All flavonoids share a common chemical 
structure: C6-C3-C6 (Figure 1). Flavonoids can be further distinguished: flavonols, 
flavones, isoflavones, flavanones, anthocyanidins and flavanols.14 Flavanols (also called 
flavan-3-ols) have attracted particular interest as they can be found in high 
Cocoa and Cardiovascular Health                                                  R2 CIRCULATIONAHA/2008/827022 
 
    
  
 6 
concentrations in certain fruits and vegetables. In the context of human nutrition, certain 
teas, grape juices and wine, various berries and especially cocoa represent noteworthy 
sources (Table 1). Flavanols occur as the monomers epicatechin and catechin which 
are the main flavanols in fruits.15 Furthermore, these monomers can form links between 
C4 and C8 allowing them to assemble as dimers, oligomers and polymers of catechins, 
the so-called procyanidins.16 Procyanidins are also known as condensed tannins which, 
through the formation of complexes with salivary proteins, are responsible for the 
bitterness of cacao.14 
After oral intake of cocoa both the flavanol content and the total antioxidant 
capacity in plasma increases. These effects appear to be markedly reduced when cocoa 
is consumed with milk or if cocoa is ingested as milk chocolate,17 however this is 
discussed controversially.18, 19The highest plasma peak concentrations of flavanols are 
obtained 2-3h after ingestion in a dose-dependent manner17, 20 and are still measurable 
after 8 hours.21 Also molecular size matters, i.e., the smaller the polypenol, the higher 
the concentration in blood. However, there is a large interpersonal variation in 
absorption. Therefore a single measurement of plasma levels at 2 h cannot be 
considered a measurement of bioavailability, but rather a check for compliance, limiting 
the usefulness of this measure.22  
Beside molecular size, there are other important factors modulating the in vivo 
efficacy of polyphenols, which must be considered, e.g. its metabolic conversion in 
intestinal cells, liver and other tissues, their binding to proteins, their accumulation in 
cells, as well as urinary elimination rate and others.23 Therefore, careful distinction 
between in vitro and in vivo effects of flavanols are mandatory. For example although 
Cocoa and Cardiovascular Health                                                  R2 CIRCULATIONAHA/2008/827022 
 
    
  
 7 
procyanidins are biologically active in vitro, they are hardly absorbed in the intestine and 
thus largely inactive in vivo. 
Importantly, during the conventional chocolate manufacturing process, from the 
fresh cocoa seeds (Figure 2) to the final product, the concentration of flavanols 
markedly decreases.24 In particular food processing methods such as fermentation and 
roasting have a detrimental impact on the final flavanol content of foods. Furthermore 
flavanol concentrations may also be dependent on the agricultural origin of the raw 
cocoa.25 In particular, milk chocolate has the lowest flavanol content as compared to 
cocoa powder and dark chocolate.26  
Although still debated, a range of potential mechanisms through which flavanols 
and cocoa might exert their benefits on cardiovascular health have been proposed 
(Figure 3), among them activation of nitric oxide, antioxidant, anti-inflammatory, as well 
as anti-platelet effects which in turn might improve endothelial function, lipid levels, 
blood pressure and insulin resistance and eventually clinical outcome.27 
 
 
POSSIBLE MECHANISMS OF THE PROTECTIVE EFFECTS OF COCOA 
Endothelial function and nitric oxide 
The endothelium is a continuous, smooth and nonthrombogenic surface of all 
blood vessels and exhibits a highly selective permeability in its healthy state. It 
synthesizes and releases a broad range of vasoactive substances. Functional 
impairment of the vascular endothelium in response to injury occurs long before the 
development of structural atherosclerotic changes. Nitric oxide (NO), synthesized by 
endothelial NO synthase (NOS) from L-arginine28 in the presence of the cofactor 
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thetrahydrobiopterin, is released form endothelial cells mainly in response to shear 
stress elicited by the circulating blood or receptor-operated substances such as 
acetylcholine, bradykinin or serotonin and others.29 NO has an in vivo half-life of only a 
few seconds and rapidly crosses biological membranes. After diffusion from endothelial 
to vascular smooth muscle cells, NO increases intracellular cyclic GMP concentrations 
and in turn induces a relaxation of vascular smooth muscle cells.30, 31 However, NO not 
only leads to vasodilation but also prevents leukocyte adhesion and migration, smooth 
muscle cell proliferation and platelet adhesion and aggregation. Reduced endothelial 
NOS expression and/or NO bioavailability is associated with endothelial dysfunction and 
eventually atherosclerotic disease.32 Indeed, endothelial dysfunction is associated with 
cardiovascular disease. Endothelial dysfunction in the forearm circulation correlates with 
coronary vascular dysfunction and is predictive of future coronary events.33-36  
In patients with coronary artery disease, food rich in flavanols mostly improves 
endothelial function, in particular short-and long-term consumption of black tea37 as well 
as of red wine38, 39. In healthy smokers green tea exerts similar effects.40 In line with 
these findings, cocoa induces NO-dependent vasodilation in the rat aorta41 as well as in 
the finger or forearm circulation of healthy humans42-44 or patients with cardiovascular 
risk factors, including diabetes (Table 2).45-49 
 The underlying mechanisms are still elusive. In cultured endothelial cells,50, 51 as 
well as the rat aorta,52 plant extracts rich in flavonoids increase endothelial NOS activity. 
Incubation of endothelial cells with flavonoid-rich red wine upregulates endothelial NOS 
mRNA and protein expression, most likely via stabilization of eNOS mRNA. 
Furthermore, endothelial cells produce up to tree times more bioactive NO than control 
cells under such conditions.53 Cocoa also lowers vascular arginase activity in human 
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endothelial cell in vitro, thus augmenting the local levels of L-arginine.54 Importantly, 
cocoa-derived flavanols induce NOS in vitro.55  
In vivo, in patients with cardiovascular risk factors including smoking, a cocoa 
drink high in flavonol content (176-185mg) rapidly enhances the circulating pool of 
bioactive NO by more than a third and in turn augments flow-mediated vasodilation.45, 48 
Moreover, infusion of L-NMMA, an inhibitor of NO-synthesis, reverses the increase in 
NO and the augmentation in endothelial function associated with cocoa intake, while 
infusion of ascorbic acid has no effect.48 Similarly, in isolated aortic rings concentrations 
of flavanols comparable to those occurring in plasma after cocoa intake induce 
endothelial-dependent relaxations. Chronic consumption of a high-flavanol diet is 
associated with a high urinary excretion of NO metabolites, consistent with an 
augmented NO production or diminished degradation.44 Finally, in humans, epicatechins 
closely mimic the vascular effects of flavanol-rich cocoa, suggesting that they represent 
the primary mediator of the beneficial effect of cocoa flavanols on vascular function.44 
At the molecular level, it appears in endothelial cells that the short term effects of 
epicatechin is mainly due to diminished inactivation of NO by free radicals through 
inhibiton of NADPH oxidase by epicatechin metabolites, whereas for the long term 
effects an increased generation of NO as a consequence of higher protein eNOS 
expression is involved.23, 56 Furthermore, pure epicatechin ingestion not only augments 
nitric oxide bioavailability, but also acutely reduces the plasma levels of enothelin-1, a 
potent endothelium-derived vasoconstrictor in healthy men.57 
Of interest, drinking a flavonoid enriched cocoa beverage results in regional 
changes of cerebral blood flow and an overall increased blood flow to grey matter for up 
to three hours as assessed by functional MRI.58 Also, in elderly humans, an increase in 
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cerebral blood flow velocity in the middle cerebral artery as measured by transcranial 
doppler ultrasound occurs,59 suggesting that cocoa flavanols may protect against 
dementia and stroke.  
 
Antioxidant properties 
Besides their direct effects on endothelial NOS expression and activity, cocoa 
flavanols and procyanidins also exert strong antioxidant effects in vitro. First evidence 
came from an experiment where extracted polyphenols form commercial cocoa delayed 
LDL oxidation.60 Other studies showed a reduction in the production of reactive oxygen 
species in activated leukocytes61 and an inhibition of ultraviolet induced DNA oxidation.62 
In humans, flavanol-rich cocoa counteracts lipid peroxidation and, therefore, lowers the 
plasma level of F2-isoprostanes, markers of in vivo lipid peroxidation63, as well as 
plasma levels of oxLDL in hypercholestorelemic patients,64 and increases overall 
antioxidant capacity.16, 20 In young healthy smokers commercially available dark 
chocolate (74% cocoa), but not white chocolate, markedly improves flow-mediated 
vasodilation and improves plasma antioxidant status suggesting that possibly not only 
an induction of endothelial NOS and in turn elevated NO levels, but also a reduction in 
the production of reactive oxidant species contributes to the enhanced endothelial 
function under these conditions46. Indeed, antioxidants may prevent NO transformation 
into peroxynitrite and in turn protect against vasoconstriction and vascular damage.65 
Oxidative stress and reduced antioxidant defense play a crucial role in the pathogenesis 
of atherosclerosis, in particular in transplant vasculopathy. We therefore recently 
assessed in a double-blind, randomized study the effect of flavonoid-rich dark chocolate 
as compared to cocoa-free control chocolate on coronary vasomotion in cardiac 
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transplant recipients. Most interestingly after consumption of 40g of dark chocolate 
induced coronary vasodilation, improved coronary vascular function, and decreased 
platelet adhesion. These beneficial effects were again paralleled by a reduction of serum 
oxidative stress, as assessed by plasma isoprostanes, and were positively related to 
serum epicatechin concentrations.66  
However, recently the antioxidative effects of cocoa have been disputed. Indeed, 
Sies,67 cautioned that fruits and vegetables contain many macro- and micronutrients in 
addition to flavanols, which may directly or through their metabolites affect total 
antioxidative capacity of plasma. The large increase in plasma total antioxidative 
capacity observed after the consumption of flavanol-rich food is probably not due to 
flavanols, but more likely the consequence of the increased uric-acid levels resulting 
from fructose metabolism.68  
 
Platelet function 
Platelet dysfunction is another hallmark of atherosclerotic vascular disease.69 
Interestingly, in addition to providing antioxidant vitamins, certain fruits and vegetables 
may also protect against thrombosis due to their high flavanol content.70 Several studies 
also demonstrated platelet inhibitory properties of cocoa.71-73 Cocoa reduces 
ADP/collagen-activated, platelet-related primary hemostasis within hours of ingestion. 
These effects were, at least in part, explained by a reduction in the ADP induced 
expression of the activated conformation of GpIIb/IIIa surface proteins. Furthermore, ex 
vivo catechin and epicatechin reduce GpIIb/IIIa expression similar to low-dose aspirin, 
thereby exerting antiplatelet effects.72 In healthy volunteers consuming 100g of dark 
chocolate, reduced platelet aggregation, an effect not seen after ingestion of white 
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chocolate or milk chocolate.74 Cocoa not only decreases platelet aggregation, but also 
adhesion. In young healthy smokers, dark chocolate reduces platelet adhesion as 
assessed by a shear stress dependent platelet test.46 Similarly, stearic acid, a saturated 
fat commonly found in chocolate reduces mean platelet volume, an index of platelet 
activation, in humans.75, 76 
 
ANTIHYPERTENSIVE EFFECTS OF COCOA  
Besides the initial observations in Kuna Indians, epidemiological support for the 
blood pressure lowering capacity of chocolate comes from the Zutphen Elderly Study. In 
this cohort of 470 males, cocoa intake was inversely related to blood pressure.13 Even 
after multivariate adjustment mean systolic blood pressure was 3.8 mmHg lower in the 
highest tertile of cocoa intake compared with the lowest tertile. Another study evaluated 
the association in between chocolate consumption and new onset of hypertension in a 
cohort of university graduates; however no protection of cocoa was observed.77 
More evidence on potential antihypertensive properties of cocoa comes from a 
recently published interventional study, which compared the long term effect of dark, as 
compared to white chocolate consumption in patients with pre- or stage I hypertension. 
Already a small amount of dark chocolate daily (6 grams) in the evening significantly 
reduced mean systolic BP by 2.9 ±1.6 mm Hg and diastolic BP by 1.9 ± 1.0 mm Hg 
without changes in body weight, plasma lipid levels, glucose, or 8-isoprostane.78 
However, serum levels of S-nitrosoglutathione, which is produced by instable NO 
reacting with thiol groups to form a stable product,79 was increased in the dark chocolate 
group. Although preliminary in nature, these changes are indicative of an increase in NO 
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production as a potential mechanism of the small reduction in BP seen with dark 
chocolate consumption.80 
Besides increased endothelial NOS activity other mechanisms may contribute to 
the anti-hypertensive effect of cocoa-rich food. Indeed either isolated or food-derived 
flavanols inhibit ACE activity in vitro.81 Whether such ACE-inhibition also occurs in vivo 
needs to be further evaluated. Finally stearic acid or theobromine82 may contribute to 
these effects. Indeed, a cross-sectional linear regression analysis within the Multiple 
Risk Factor Intervention Trial found, that stearic acid levels are inversely associated with 
diastolic blood pressure.83 
No matter what mechanism is responsible, several independent, albeit small 
studies indicate that ingestion of cocoa-rich chocolate has blood pressure lowering 
effects. One study reported reduction in systolic and diastolic blood pressure in 
hypertensive elderly subjects84 and another one noted a decrease in daytime and 
nighttime blood pressure, as assessed by ambulatory 24 hour measurements, after 
intake of 100g flavonoid-rich dark chocolate daily for 2 weeks.47 In the later study, 
systolic blood pressure decreased after consumption of dark chocolate by 12 mmHg, 
whereas white chocolate had no effect. However, other studies showed no effect on 
blood pressure.42, 43 As the latter studies where performed in a relatively small number of 
normotensive individuals and with a lower chocolate intake of shorter duration, an 
antihypertensive effect may have been missed due to their study design.42 
A recent meta-analysis of randomized controlled studies of cocoa administration 
(173 subjects, mean duration 2 weeks) confirmed a significant reduction in pressure: 
Mean systolic and diastolic blood pressure were reduced by 4.7 mm Hg (95% CI, 7.6 to 
1.8 mmHg; p = .002) and 2.8 mmHg (95% CI, 4.8 to 0.8 mm Hg; p = .006) respectively.85 
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This finding is remarkable, as the blood pressure lowering effects of currently used 
antihypertensive drugs are in the same range.  
Considering the small number of subjects studied so far and the variable dose of 
flavanols and/or chocolate used, a large well controlled interventional study appears 
warranted.   
Since the demonstration that already treatment of prehypertensive subjects with 
candesartan reduced the risk of incident hypertension, there is an ongoing discussion 
about the therapeutic need in this large population.86 Therefore the response to flavanol-
rich cocoa in subjects with prehypertensive (JNC VII, 120-139mmHg) or high normal 
(ESC 130-139mmHg) blood pressure would be particularly interesting as it could have 
the potential to delay the onset of hypertension in this population.  
 
COCOA AND OTHER ANTI-ATHEROGENIC EFFECTS  
Insulin Resistance 
Insulin sensitivity is partly dependent on insulin-mediated NO release.87 Thus, 
flavanols and dietary antioxidants may decrease insulin resistance by ameliorating NO 
bioavailability. In line with this concept, Grassi et al. reported reduced insulin resistance 
in patients with essential hypertension after a 15 day diet with 100g of flavonoid-rich 
chocolate daily.47, 88 Moreover, in hypertensive patients with impaired glucose tolerance 
flavonoid rich dark chocolate not only reduced blood pressure and improved endothelial 
function but also ameliorated insulin sensitivity and ß-cell function.89 As intravenous 
infusion of ascorbic acid not only improves FMD but also insulin sensitivity in subjects 
with impaired glucose tolerance as well as in smokers,90 the antioxidant properties of 
flavanols might contribute to these beneficial effects of coca on insulin sensitivity.  
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However, as studies with cocoa in diabetics are scarce and since diabetics tend 
to be obese, caution should be exerted before recommending cocoa or flavonoid-rich 
chocolate consumption to such patients.  Nevertheless, experimental evidence in obese 
diabetic mice suggest that cocoa dose-dependently prevents hyperglycaemia.91 
 
Blood lipids 
Cocoa butter, a fat derived from cocoa plants and predominately found in dark 
chocolate contains an average of 33% monounsaturated oleic acid and 33% of stearic 
acid. In general, plant stearic acid neither lowers HDL, nor increases LDL or total 
cholesterol.92, 93 Interestingly, in a study involving young healthy subjects consumption of 
a milk chocolate bar (46gram) instead of a high-carbohydrate snack increased HDL 
cholesterol and decreased plasma triglycerides, while it did not affect LDL, despite an 
increase in total fat in the diet.94 In hypertensive patients, daily consumption of 100 g 
flavonoid rich chocolate over two weeks lead to a significant 12% reduction of serum 
total and LDL cholesterol levels.47 Moreover, cocoa appears to inhibit LDL oxidation.95 In 
healthy subjects daily consumption of 75g of polyphenol-rich dark chocolate over 3 
weeks increases HDL cholesterol by up to 14%, and inhibits lipid peroxidation.96 A 
recent Japanese study demonstrates that in hypercholesterolemic patients flavanol rich 
cocoa lowers plasma levels of LDL and oxLDL as well as increases HDL serum 
concentrations.64, 97  
Overall, the effects of chocolate and its various components on lipid levels are not 
conclusive, strongly suggesting that a larger well-controlled study appears mandatory. 
Importantly, however, in spite of its high fat content cocoa itself does not seem to exert 
untoward effects on lipid metabolism. It must be stressed that many chocolate products 
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contain milk or processed fats, for example palm oils. The effect of processed chocolate 
on blood lipids is not known and may indeed be less favorable.  
 
PRECAUTIONS AND LIMITATIONS  
Although many positive effects of chocolate and its ingredients have been 
documented in the cardiovascular system, precautions in its use are mandatory. Indeed, 
the high caloric load of commercially available chocolate (about 500 kcal/100g) may 
induce weight gain, a risk factor for hypertension, dyslipidemia and diabetes. 
Surprisingly, a study in 49 healthy women showed no weight gain after daily 
consumption of either 41g chocolate, 60g almonds or almonds and chocolate together 
for 6 weeks.98 Thus, weight gain may only occur with higher amounts of daily chocolate 
and/or its prolonged use. Furthermore, the occasionally high sugar and fat content of 
commercially available chocolate has to be considered. As high sugar intake is 
associated with obesity, caries and diabetes, cocoa-based products with no or only low 
sugar content should certainly be preferred. On the other hand, cocoa itself, unlike 
chocolate, can be recommended without hesitation, as it is low in sugar and fat. 
Although further research is required, current evidence suggests that the beneficial 
effects of cocoa are mainly attributed to its flavanol content, especially epicatechin. 
Therefore direct dietary supplementation with flavanols instead of chocolate 
consumption deserves further study. Indeed, protocols using specifically epicatechin or 
other flavanoids are now feasible and should clarify this question. At this point, it 
appears problematic to recommend dietary supplementation with flavanols, as – similar 
to the vitamins - potential pro-oxidative effects of large quantities cannot be excluded. 99  
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Because of the limitations of the data available so far, future studies should 
provide detailed information about the chocolate-product used, the exact content in 
polyphenols, especially flavanols, and, most importantly about the flavanol plasma 
concentrations achieved. Furthermore, it has to be taken into account that cocoa 
contains many other, potentially active substances, as for example theobromine or 
magnesium, substances not discussed in this review. 
Finally, to definitively clarify the protective effects of cacao on cardiovascular 
health, larger studies with a placebo controlled prospective design focusing initially on 
surrogate endpoints such as carotid atherosclerosis and eventually also on morbidity 
and mortality are needed. 
 
CONCLUSION 
For many centuries, cocoa has been known for its good taste as well as its 
beneficial effects on health. Recent research revealed that cocoa does indeed exert 
beneficial cardiovascular effects, probably mainly mediated by its polyphenols, a 
heterogeneous group of molecules mainly found in fruits and vegetables. The beneficial 
effects of cacao are most likely due to an increased bioavailability of NO. This may 
explain the improvement in endothelial function, the reduction in platelet function as well 
the potentially beneficial effects on blood pressure, insulin resistance and blood lipids.  
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Figure Legends 
 
Figure 1. Health relevant effect of Epicatechins 
 
Figure 2. The fruit of the cocoa trea “theobroma cocoa” 
 
Figure 3. Endothelium dependent effect of cocoa polyphenols. 
NO is released form endothelial cells mainly in response to shear stress elicited by the 
circulating blood or receptor-operated substances such as acetylcholine, bradykinin or 
serotonin and others. Nitric oxide (NO) is synthesized by endothelial NO synthase 
(eNOS) from L-arginine in the presence of the cofactor thetrahydrobiopterin. The 
activation may be due to an increase in Ca2+ or a phosphorylation of eNOS by the PI3-
kinase/Akt pathway. Cocoa also lowers vascular arginase activity in human endothelial 
cell in vitro, thus augmenting the local levels of L-arginine. Once released, NO increases 
intracellular cyclic GMP concentrations and in turn induces a relaxation of vascular 
smooth muscle cells. NO not only leads to vasodilation but also prevents leukocyte 
adhesion and migration, smooth muscle cell proliferation and platelet adhesion and 
aggregation. Other then NO mediated mechanisms are discussed. Antioxidant effects 
may reduce the production of reactive oxidant species thus contributing to an enhanced 
endothelial function. Cocoa polyphenols may activate endothelium-derived 
hyperpolarizing factor (EDHF), increase endothelial prostacyclin release or inhibit the 
synthesis of endothelin-1.  Moreover, polyphenols may directly inhibit ACE enzyme.  
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Table 1: Catechin/Epicatechin Concentrations found in food14 
Source Flavanol content per mg/kg or mg/L 
Chocolate 460-610 
Beans 350-550 
Apricot 100-250 
Cherry 50-220 
Peach 50-140 
Blackberry 130 
Apple 20-120 
Green tea 100-800 
Black tea 60-500 
Red wine 80-300 
Cider 40 
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Table 2.  Studies investigating Cocoa and endothelial function 
 
Author Year No  Animals/ 
Patients 
Duration Intervention Outcome 
Karim41 2000 5 Aortic rings form 
rats 
Immediately Procyanidins 
derived from 
cocoa 
Endothelial derived relaxation mediated by 
activation of NOS 
Fisher42 2003 27 Healthy people 5 days Flavanol rich 
cocoa (821mg/d) 
Peripheral vasodilatation, improved vasodilator 
response to ischemia assessed by pulse wave 
amplitude on the finger 
Engeler43 2004 21 Healthy subjects 2 weeks High flavonoid 
chocolate (213mg 
procyanidins, 
46mg 
epicatechin) vs. 
low flavonoid 
chocolate 
Improvement of flow mediated vasodilatation of the 
brachial artery, increased epicatechin 
concentrations 
Schroeter44 2006 16 Healthy subjects, 
isolated rabbit 
rings 
 Drink with high 
flavonoid content 
Improvement of flow mediated vasodilatation, 
paralleled the appearance of flavanoles in plasma. 
Concentrations in plasma enough to mediate ex 
vivo vasodilatation. Pure epicatecins mimics 
vascular effects of cocoa. High flavanol diet is 
associated with high urinary excretion of NO 
metabolites 
Heiss45 2003 26 Patients with at 
least 1 
cardiovascular 
risk factor 
2 hours 
(crossover) 
Flavanol rich 
cocoa drink 
(100ml) 
Improvement of flow mediated vasodilatation and 
increased levels of nitrosated and nitrosylated 
species. 
Hermann46 2006 20 Healthy smokers 2 hours 40g commercially 
available dark 
chocolate vs. 
white chocolate 
Increase in flow mediated vasodilatation of the 
brachial artery. Improvement of antioxidant status 
and improvement of platelet function. 
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Grassi47  2005 20 Untreated 
essential 
hypertension 
15 days 
(crossover) 
100 g dark 
chocolate 
(21.91mg 
catechin, 65,97 
mg epicatechins) 
vs. flavanol free 
white chocolate 
Increased flow mediated vasodilatation of the 
brachial artery. Decrease in blood-pressure and 
LDL cholesterol, increase of insulin sensitivity 
Heiss48 2005 11 Smokers 2 hours 
(crossover) 
100ml cocoa 
drink with high 
(176-18mg) or 
low (<11mg) 
flavanol content 
 
Increase of flow-mediated vasodilatation and 
circulating NO pool. Increase of flavanol 
metabolites 
Balzer49 2008 41 Diabetes 4 weeks Drink with high 
flavanol content 
Improvement in flow-mediated vasodilatation (acute 
and chronic) 
Flammer66 2007 22 Heart transplant 
recipients 
2 hours 40g commercially 
available dark 
chocolate vs. 
flavonoid free 
placebo 
chocolate 
Inducing coronary vasodilation, improvement in 
coronary endothelial function and improvement of 
platelet function. 
Grassi89 2008 19 Hypertensives, 
impaired glucose 
tolerance 
2 weeks Flavanol-rich darc 
chocolate 
Improvement in flow-mediated vasodilatation, 
insulin sensitivity, beta-cell function, and blood 
pressure  
Shiina100 2008 39 Healthy 2 weeks 45g commercially 
available dark 
chocolate vs. 
white chocolate 
Improvement in coronary circulation as measured 
by coronary velocity flow reserve 
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